T
Thierry de Baere
Researcher at Institut Gustave Roussy
Publications - 280
Citations - 15079
Thierry de Baere is an academic researcher from Institut Gustave Roussy. The author has contributed to research in topics: Medicine & Radiofrequency ablation. The author has an hindex of 61, co-authored 251 publications receiving 12099 citations. Previous affiliations of Thierry de Baere include Anschutz Medical Campus & University of Pisa.
Papers
More filters
Journal ArticleDOI
Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update
Muneeb Ahmed,Luigi Solbiati,Christopher L. Brace,David J. Breen,Matthew R. Callstrom,J. William Charboneau,Min-hua Chen,Byung Ihn Choi,Thierry de Baere,Gerald D. Dodd,Damian E. Dupuy,Debra A. Gervais,David Gianfelice,Alice Gillams,Fred T. Lee,Edward Leen,Riccardo Lencioni,Peter Littrup,T. Livraghi,David S.K. Lu,John P. McGahan,Maria Franca Meloni,Boris Nikolic,Philippe L. Pereira,Ping Liang,Hyunchul Rhim,Steven C. Rose,Riad Salem,Constantinos T. Sofocleous,Stephen B. Solomon,Michael C. Soulen,Masatoshi Tanaka,Thomas J. Vogl,Bradford J. Wood,S. Nahum Goldberg +34 more
TL;DR: This updated consensus document provides a framework that will facilitate the clearest communication among investigators regarding ablative technologies and improve the precision of communications in this field, leading to more accurate comparison of technologies and results, and ultimately to improved patient outcomes.
Journal ArticleDOI
High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: Results of the MOSCATO 01 trial
Christophe Massard,Stefan Michiels,Charles Ferté,Marie-Cécile Le Deley,Ludovic Lacroix,Antoine Hollebecque,Loic Verlingue,Ecaterina Ileana,Silvia Rosellini,Samy Ammari,Maud Ngo-Camus,Rastislav Bahleda,Anas Gazzah,Andrea Varga,Sophie Postel-Vinay,Yohann Loriot,Caroline Even,Ingrid Breuskin,Nathalie Auger,Bastien Job,Thierry de Baere,Frederic Deschamps,Philippe Vielh,Jean-Yves Scoazec,Vladimir Lazar,Catherine Richon,Vincent Ribrag,Eric Deutsch,Eric Angevin,Gilles Vassal,Alexander M.M. Eggermont,Fabrice Andre,Jean-Charles Soria +32 more
TL;DR: This study suggests that high-throughput genomics could improve outcomes in a subset of patients with hard-to-treat cancers, although these results are encouraging, only 7% of the successfully screened patients benefited from this approach.
Journal ArticleDOI
Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.
Riccardo Lencioni,Thierry de Baere,Michael C. Soulen,William S. Rilling,Jean Francois H. Geschwind +4 more
TL;DR: In a systematic literature review, survival figures of HCC patients undergoing lipiodol TACE appear to be in line with those reported in previous RCTs, and no new or unexpected safety concerns were identified.
Journal ArticleDOI
Adverse events during radiofrequency treatment of 582 hepatic tumors.
Thierry de Baere,O. Risse,V. Kuoch,Clarisse Dromain,Christophe Sengel,Tarek Smayra,Mostafa Gamal El Din,Christian Letoublon,Dominique Elias +8 more
TL;DR: Radiofrequency ablation of liver tumors is a well-tolerated technique, but caution should be exercised when treating patients with a bilioenteric anastomosis, and radio frequencies ablation during vascular occlusion in cirrhotic livers should be avoided.
Journal ArticleDOI
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.
Thierry de Baere,Dominique Elias,Clarisse Dromain,Mostafa Gamal El Din,V. Kuoch,Michel Ducreux,Valérie Boige,Nathalie Lassau,Veronique Marteau,Philippe Lasser,Alain Roche +10 more
TL;DR: Radiofrequency ablation appears to be a promising therapeutic modality capable of extending the possibilities of partial hepatectomy and of efficiently treating small metastases percutaneously.